Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Messing

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Cancer Research|December 31, 2011
A positive feedback signaling loop between ATM and the vitamin D receptor is critical for cancer chemoprevention by vitamin DHuei-Ju Ting, Sayeda Yasmin-Karim, Shian-Jang Yan, et al.
The Journal of Urology|September 25, 2017
Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical ProstatectomyHao G Nguyen, Christopher Welty, Karla Lindquist, et al.
Urology|February 17, 2012
Near infrared fluorescence imaging after intravenous indocyanine green: initial clinical experience with open partial nephrectomy for renal cortical tumorsScott Tobis, Joy K Knopf, Christopher R Silvers, et al.
Urology|January 10, 2006
Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markersTomonori Habuchi, Michael Marberger, Michael J Droller, et al.
Urology|January 10, 2006
Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markersVinata B Lokeshwar, Tomonori Habuchi, H Barton Grossman, et al.
Urologic Oncology|June 17, 2014
Micropapillary bladder cancer: current treatment patterns and review of the literatureDaniel L Willis, Thomas W Flaig, Donna E Hansel, et al.
Journal of Translational Medicine|May 9, 2026
Detection of bladder cancer in patients with microscopic hematuria using Oncuria-Detect: results of a prospective, multicenter international studyYair Lotan, Satoshi Anai, Howard Kim, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 2, 2012
A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patientsEdward Messing, Jason R Gee, Daniel R Saltzstein, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 27, 2024
Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer SurgeryTracy M Downs, Howard H Bailey, Taja Lozar, et al.
Urologic Oncology|July 29, 2014
Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forwardAndrea B Apolo, Vanessa Hoffman, Matthew G Kaag, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Cancer Research|December 31, 2011
A positive feedback signaling loop between ATM and the vitamin D receptor is critical for cancer chemoprevention by vitamin DHuei-Ju Ting, Sayeda Yasmin-Karim, Shian-Jang Yan, et al.
The Journal of Urology|September 25, 2017
Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical ProstatectomyHao G Nguyen, Christopher Welty, Karla Lindquist, et al.
Urology|February 17, 2012
Near infrared fluorescence imaging after intravenous indocyanine green: initial clinical experience with open partial nephrectomy for renal cortical tumorsScott Tobis, Joy K Knopf, Christopher R Silvers, et al.
Urology|January 10, 2006
Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markersTomonori Habuchi, Michael Marberger, Michael J Droller, et al.
Urology|January 10, 2006
Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markersVinata B Lokeshwar, Tomonori Habuchi, H Barton Grossman, et al.
Urologic Oncology|June 17, 2014
Micropapillary bladder cancer: current treatment patterns and review of the literatureDaniel L Willis, Thomas W Flaig, Donna E Hansel, et al.
Journal of Translational Medicine|May 9, 2026
Detection of bladder cancer in patients with microscopic hematuria using Oncuria-Detect: results of a prospective, multicenter international studyYair Lotan, Satoshi Anai, Howard Kim, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 2, 2012
A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patientsEdward Messing, Jason R Gee, Daniel R Saltzstein, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 27, 2024
Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer SurgeryTracy M Downs, Howard H Bailey, Taja Lozar, et al.
Urologic Oncology|July 29, 2014
Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forwardAndrea B Apolo, Vanessa Hoffman, Matthew G Kaag, et al.
Pageof 8